Intratio
Loading...
Skip to main content
Model output · Signal date 2026-11-06

Elevance Health, Inc. (ELV) Stock Forecast Nov. 6, 2026

Analysis updated on Nov. 6, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE

Share
X LinkedIn Reddit WhatsApp Telegram
Embed badge
Unlock full AI forecasts
Rating · 90D Unlock rating and forecasts
90-day forecast Sign up free to reveal
30-day forecast Alpha
Rank in coverage of 5150 stocks scored
Rank correlation · 90D 42.0% Spearman, 357 dates
Market Cap $91.96B large-cap · #2 of 10 peers
Summary

Elevance Health, Inc. (ELV) stock forecast summary

Our AI scores Elevance Health, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.

Elevance Health, Inc. is a large-cap company with a market capitalization of $91.96B. It ranks number 2 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast.

For ELV, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 42.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 19.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +3.1%, buy ≥ +1.5%, sell < -0.5%, strong sell < -1.8% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-11-06 signals)

A free account shows the exact forecast, rating and rank of 3 tickers you follow, ELV included.

Price

ELV price chart and AI forecast

ELV
Cross-section · 2026-11-06

How ELV ranks among 5150 stocks

90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

Fundamentals · 2026-09-30

Elevance Health, Inc. (ELV) fundamentals

Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.

Valuation & Market

MetricELVIndustry medianRank
Market Cap $91.96B $22.92B 2/10
P/E Ratio 18.07x 22.46x 5/7
P/B Ratio 2.06x 3.19x 8/10
Dividend Yield 1.63% – –
EPS $23.56 – –
Book Value/Share $206.80 – –
Revenue/Share $934.16 – –
FCF/Share $30.15 – –

Profitability & Margins

MetricELVIndustry medianRank
ROE 11.5% 11.5% 4/7
ROA 4.0% 3.8% 3/7
ROIC 6.7% 6.9% 6/10
Gross Margin 89.0% 54.5% 2/6
Operating Margin 2.7% 1.7% 4/10
Net Margin 2.5% 2.1% 3/7
EBT Margin 3.1% 1.5% 3/10
Tax Rate 18.4% – –

Financial Health

MetricELVIndustry medianRank
Current Ratio 1.47x 1.51x 6/10
D/E Ratio 1.86x 2.34x 8/10
Financial Leverage 2.86x 3.38x 8/10
Interest Coverage 4.7x 6.0x 5/6
Working Capital $21.86B $752M 1/10

Cash Flow

MetricELVIndustry medianRank
Operating Cash Flow $7.60B $3.96B 3/10
Free Cash Flow $6.51B $3.14B 2/9
Capital Spending -$1.08B -$93M 8/9
OCF Growth YoY 54.6% 20.6% 3/8
FCF Growth YoY 72.9% 31.4% 3/7
FCF/Sales 3.2% 3.2% 5/9
CapEx/Sales 0.5% 0.4% 4/9

Operational Efficiency

MetricELVIndustry medianRank
Asset Turnover 1.58x 2.19x 9/10
Fixed Assets Turnover 43.8x 75.5x 8/10

Income Statement

MetricELVIndustry medianRank
Total Revenue $201.83B $99.16B 4/10
Operating Income $5.43B $972M 3/10
Net Income $5.14B $1.46B 3/7
SG&A Expense $23.04B $13.76B 2/8
Cost of Goods Sold $22.12B $30.34B 4/6

Dividend & Shareholder Information

MetricELVIndustry medianRank
Dividends Per Share $6.94 – –
Payout Ratio 29.5% – –
Shares Outstanding 216M – –
Net Income Growth -7.1% -3.5% 4/5
EPS Growth -4.0% -4.0% 3/5

Balance Sheet Highlights (USD millions)

Total Current Assets$68.52B53.6% of assets
Cash & Short-term Investments$10.35B8.1% of assets
Total Liabilities$83.01B65.0% of assets
Quarterly Financial Reports

ELV quarterly financials and insider trading

Industry Peers · Hospital & Medical Service Plans

Elevance Health, Inc. (ELV) industry peers

Companies classified under the same SEC industry code as Elevance Health, Inc. (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.

Reveal all forecasts · See exact % predictions for all competitors

Sign up free
Company 90-Day AI Forecast (Alpha) Market Cap P/E Ratio P/B Ratio
ELV Elevance Health, Inc. $91.96B 18.1x 2.1x
UNH Unitedhealth Group Inc $353.79B 22.5x 3.6x
CI Cigna Group $77.58B 13.0x 1.8x
HUM Humana Inc $52.17B 42.2x 2.8x
CNC Centene Corp $34.53B 23.2x 1.6x
MOH Molina Healthcare, Inc. $11.31B – 2.7x
OSCR Oscar Health, Inc. $9.46B 12.3x 4.3x
CLOV Clover Health Investments, Corp. /De $2.56B – 6.6x
TRUP Trupanion, Inc. $1.61B 69.3x 4.0x
ALHC Alignment Healthcare, Inc. $1.54B – 5.5x

Where ELV sits on the market map

Finance · Hospital & Medical Service Plans
Explore the map →
News

Elevance Health, Inc. (ELV) stock news

Loading...

FAQ

Elevance Health, Inc. (ELV) stock forecast FAQ

What is the Elevance Health, Inc. (ELV) stock forecast?

Our AI scores Elevance Health, Inc. every trading day against every stock it covers. Create a free account and follow it to see its rating and price target.

How accurate are Elevance Health, Inc. stock predictions?

For ELV, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 42.0%, measured on 357 forecast dates between 2022-08-19 and 2026-08-07 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 19.0%, measured on 400 forecast dates between 2022-08-19 and 2026-10-07. Across our coverage, the out-of-sample test on 4629 stocks from 2025-01-06 to 2026-08-04 produced a positive net return in 92.9% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

How often are Elevance Health, Inc. forecasts updated?

Elevance Health, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Nov. 6, 2026.

Which companies are Elevance Health, Inc.'s industry peers?

10 issuers in our coverage, ELV included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Cigna Group (CI), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH), Oscar Health, Inc. (OSCR).

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.